Table 3.
Additional details on perioperative antifungal prophylaxis.
| Liposomal Amphotericin B iv. Plus Inhaled Amphotericin B Lipid Complex (n = 112, 71%) |
Liposomal Amphotericin B iv. (n = 33, 21%) |
Azoles or Echinocandins (n = 12, 8%) |
p-Value | |
|---|---|---|---|---|
| Antifungal therapies and biomarkers | ||||
| FI, n (%) | 9 (8) | 2 (6) | 2 (17) | 0.29 |
| Fungal colonization, n (%) | 25 (22) | 6 (16) | 5 (42) | 0.29 |
| Others, n (%) | 78 (70) | 25 (76) | 5 (42) | 0.29 |
Abbreviations: n, numbers; FI, fungal infection; i.v., intravenous; min, minutes; BAL, bronco-alveolar lavage.